4.5 Article

Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women

期刊

OSTEOPOROSIS INTERNATIONAL
卷 24, 期 1, 页码 69-76

出版社

SPRINGER LONDON LTD
DOI: 10.1007/s00198-012-2209-1

关键词

Body composition; Cohort study; Epidemiology; Obesity; Osteoporosis

资金

  1. Japan Osteoporosis Foundation

向作者/读者索取更多资源

This cohort study of 1,614 postmenopausal Japanese women followed for 6.7 years showed that overweight/obesity and underweight are both risk factors for fractures at different sites. Fracture risk assessment may be improved if fracture sites are taken into account and BMI is categorized. The effect of body mass index (BMI) on fracture at a given level of bone mineral density (BMD) is controversial, since varying associations between BMI and fracture sites have been reported. A total of 1,614 postmenopausal Japanese women were followed for 6.7 years in a hospital-based cohort study. Endpoints included incident vertebral, femoral neck, and long-bone fractures. Rate ratios were estimated by Poisson regression models adjusted for age, diabetes mellitus, BMD, prior fracture, back pain, and treatment by estrogen. Over a mean follow-up period of 6.7 years, a total of 254 clinical and 335 morphometric vertebral fractures, 48 femoral neck fractures, and 159 long-bone fractures were observed. Incidence rates of vertebral fracture in underweight and normal weight women were significantly lower than overweight or obese women by 0.45 (95 % confidence interval: 0.32 to 0.63) and 0.61 (0.50 to 0.74), respectively, if BMD and other risk factors were adjusted, and by 0.66 (0.48 to 0.90) and 0.70 (0.58 to 0.84) if only BMD was not adjusted. Incidence rates of femoral neck and long-bone fractures in the underweight group were higher than the overweight/obese group by 2.15 (0.73 to 6.34) and 1.51 (0.82 to 2.77) and were similar between normal weight and overweight/obesity. Overweight/obesity and underweight are both risk factors for fractures at different sites. Fracture risk assessment may be improved if fracture sites are taken into account and BMI is categorized.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study

Hiroshi Moritake, Shiro Tanaka, Takako Miyamura, Hideki Nakayama, Norio Shiba, Akira Shimada, Kiminori Terui, Yuki Yuza, Katsuyoshi Koh, Hiroaki Goto, Harumi Kakuda, Akiko Saito, Daisuke Hasegawa, Shotaro Iwamoto, Takashi Taga, Souichi Adachi, Daisuke Tomizawa

Summary: The prognosis of relapsed pediatric AML depends on the duration from diagnosis to relapse and achieving a second complete remission (CR2) prior to HCT. Treatment with ECM or FLAG-based regimens may improve outcomes, while genetic factors like FLT3-internal tandem duplication can serve as poor prognostic markers.

PEDIATRIC BLOOD & CANCER (2021)

Article Endocrinology & Metabolism

A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study

Masaru Kitazawa, Takashi Katagiri, Hiromi Suzuki, Satoshi Matsunaga, Mayuko Yamada, Tomoo Ikarashi, Masahiko Yamamoto, Kazuo Furukawa, Midori Iwanaga, Mariko Hatta, Kazuya Fujihara, Takaho Yamada, Shiro Tanaka, Hirohito Sone

Summary: This study compared the long-term efficacy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors as second-line drugs in patients not at high risk of ASCVD. The results showed no significant difference in achieving the primary endpoint at 52 weeks, but sitagliptin had a higher HbA1c reduction rate at 24 weeks.

DIABETES OBESITY & METABOLISM (2021)

Article Gastroenterology & Hepatology

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial

Raghav Sundar, Nesaretnam Barr Kumarakulasinghe, Yiong Huak Chan, Kazuhiro Yoshida, Takaki Yoshikawa, Yohei Miyagi, Yasushi Rino, Munetaka Masuda, Jia Guan, Junichi Sakamoto, Shiro Tanaka, Angie Lay-Keng Tan, Michal Marek Hoppe, Anand D. Jeyasekharan, Cedric Chuan Young Ng, Mark De Simone, Heike Grabsch, Jeeyun Lee, Takashi Oshima, Akira Tsuburaya, Patrick Tan

Summary: In the SAMIT trial, a gene signature predicting survival benefit from paclitaxel chemotherapy in gastric cancer patients was identified using machine-learning techniques. Patients were divided into Pac-Sensitive and Pac-Resistant groups, with Pac-Sensitive patients showing significant improvement in disease-free survival. This gene signature was validated in an external cohort, providing the first predictive biomarker for paclitaxel benefit in gastric cancer patients.
Article Endocrinology & Metabolism

Developing a health economic model for Asians with type 2 diabetes based on the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial

Shiro Tanaka, Jakob Langer, Tim Morton, Nicki Hoskins, Lars Wilkinson, Sachiko Tanaka-Mizuno, Ryo Kawasaki, Tatsumi Moriya, Chika Horikawa, Rei Aida, Atsushi Araki, Kazuya Fujihara, Hirohito Sone

Summary: This study presents an economic model developed specifically for evaluating the cost-effectiveness of two interventions for type 2 diabetes in a Japanese population. By simulating analyses in different age groups, the model can estimate rates of diabetic complications, costs, quality-adjusted life years, and provide disaggregated results for competing interventions.

BMJ OPEN DIABETES RESEARCH & CARE (2021)

Article Endocrinology & Metabolism

Influence of symptomatic periodontal disease on changes in skeletal bone density during medication therapy for osteoporosis in postmenopausal women: the Japanese Osteoporosis Intervention Trial (JOINT)-04 and JOINT-05

Akira Taguchi, Yukari Uemura, Shiro Tanaka, Hiroaki Ohta, Satoshi Mori, Hiroshi Hagino, Masataka Shiraki, Toshitaka Nakamura, Satoshi Soen

Summary: This study found that postmenopausal Japanese women with symptomatic periodontal disease had a significantly smaller increase in total hip bone density compared to those without periodontal disease during medication therapy for osteoporosis. Interventions to treat symptomatic periodontal disease before and/or during osteoporosis therapy could help maintain the effectiveness of osteoporosis medications.

ARCHIVES OF OSTEOPOROSIS (2022)

Article Oncology

Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study

Norihiro Shimoike, Tatsuto Nishigori, Yoshito Yamashita, Masato Kondo, Dai Manaka, Yoshio Kadokawa, Atsushi Itami, Seiichiro Kanaya, Hisahiro Hosogi, Seiji Satoh, Hiroaki Hata, Takatsugu Kan, Hironori Kawada, Michihiro Yamamoto, Eiji Tanaka, Shigeru Tsunoda, Shigeo Hisamori, Koya Hida, Kentaro Ueno, Shiro Tanaka, Kazutaka Obama

Summary: The study evaluated the safety of robotic gastrectomy in daily clinical practice and assessed the learning process in surgeons introduced to robotic procedures. Results showed that robotic gastrectomy was safely performed in actual clinical settings, although initial cases had longer operative time and promoted greater levels of surgeon fatigue compared to subsequent cases.

GASTRIC CANCER (2022)

Letter Endocrinology & Metabolism

Predictors of haemoglobin levels and of changes in these levels, focusing on anaemia and polycythaemia after administration of the sodium-glucose cotransporter-2 inhibitor tofogliflozin

Yasuhiro Matsubayashi, Alkihiro Yoshida, Hideki Suganami, Momoko Oe, Takaaki Sato, Yuta Yaguchi, Kazuya Fujihara, Takaho Yamada, Shiro Tanaka, Kohei Kaku, Hirohito Sone

DIABETES OBESITY & METABOLISM (2022)

Article Endocrinology & Metabolism

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05

Satoshi Mori, Hiroshi Hagino, Toshitsugu Sugimoto, Shiro Tanaka, Yuji Mitomo, Kaito Takahashi, Teruki Sone, Toshitaka Nakamura, Satoshi Soen

Summary: This study aimed to determine whether sequential therapy with teriparatide, followed by alendronate, is more effective in preventing fractures compared to monotherapy with alendronate. The results showed that in women with osteoporosis at high risk of fracture, once-weekly teriparatide injection followed by alendronate significantly reduced the incidence of morphometric vertebral fractures compared to alendronate monotherapy.

OSTEOPOROSIS INTERNATIONAL (2023)

Meeting Abstract Hematology

Safety and Efficacy of Arsenic Trioxide in the Treatment of Newly Diagnosed Pediatric Acute Promyelocytic Leukemia: Results from the JPLSG AML-P13 Study

Hiroyuki Takahashi, Shiro Tanaka, Yuki Yuza, Yuka Iijima-Yamashita, Daisuke Hasegawa, Hiroshi Moritake, Kiminori Terui, Shotaro Iwamoto, Akira Shimada, Jun Matsubayashi, Takao Deguchi, Yoshiko Hashii, Nobutaka Kiyokawa, Hayato Miyachi, Akiko Moriya Saito, Takashi Taga, Souichi Adachi, Daisuke Tomizawa

Meeting Abstract Hematology

Evaluation of High-Dose Cytarabine Induction Therapy and Flow Cytometric Measurable Residual Disease Monitoring for Children with De Novo Acute Myeloid Leukemia: A Report from the JPLSG-AML-12 Trial

Daisuke Tomizawa, Shiro Tanaka, Shotaro Iwamoto, Hidefumi Hiramatsu, Jun Matsubayashi, Daisuke Hasegawa, Hiroshi Moritake, Daiichiro Hasegawa, Kiminori Terui, Asahito Hama, Shin-ichi Tsujimoto, Nobutaka Kiyokawa, Hayato Miyachi, Takao Deguchi, Yoshiko Hashii, Yuka Iijima-Yamashita, Tomohiko Taki, Yasushi Noguchi, Kazutoshi Koike, Katsuyoshi Koh, Yuki Yuza, Akiko Moriya Saito, Keizo Horibe, Takashi Taga, Souichi Adachi

Article Public, Environmental & Occupational Health

Risk Ratio and Risk Difference Estimation in Case-cohort Studies

Hisashi Noma, Munechika Misumi, Shiro Tanaka

Summary: Ordinary logistic regression analyses are widely used in case-cohort studies, but their odds ratio estimates cannot be interpreted as relative risk measures unless the event rate is low. This study introduces pseudo-Poisson and pseudo-normal linear regression methods that can estimate risk ratios and risk differences. By using weighting and auxiliary variable information, these estimators provide accurate and precise results. These alternative approaches are recommended for case-cohort studies, especially when the event rate is not low.

JOURNAL OF EPIDEMIOLOGY (2023)

Article Endocrinology & Metabolism

Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene

Hiroaki Ohta, Yukari Uemura, Teruki Sone, Shiro Tanaka, Satoshi Soen, Satoshi Mori, Hiroshi Hagino, Masao Fukunaga, Toshitaka Nakamura, Hajime Orimo, Masataka Shiraki

Summary: The positive link between osteoporosis and hypercholesterolemia has been acknowledged, and bone resorption inhibitors, such as nitrogen-containing bisphosphonates (N-BP) and selective estrogen receptor modulators (SERMs), have been found to lower serum cholesterol levels. However, the association between baseline cholesterol level and incident fracture rate under treatment with these inhibitors has not been studied. This research investigated the relationship between vertebral fracture incidents and baseline cholesterol levels, as well as the cholesterol-lowering effects of N-BP and SERM in osteoporosis patients.

CALCIFIED TISSUE INTERNATIONAL (2023)

Article Public, Environmental & Occupational Health

Antiresorptive drugs and the risk of femoral shaft fracture in men and women with osteoporosis: A cohort study using the National Database of Health Insurance Claims of Japan

Takumi Imai, Takayuki Hosoi, Hiroshi Hagino, Takanori Yamamoto, Tatsuhiko Kuroda, Hiroshi Watanabe, Shiro Tanaka

Summary: This study aimed to estimate the incidence rates of femoral shaft fracture in patients treated with antiresorptive drugs. The study found variations in the incidence rates of femoral shaft fracture among patients treated with different types of antiresorptive drugs.

JOURNAL OF EPIDEMIOLOGY (2022)

Article Endocrinology & Metabolism

Association of Urinary Pentosidine Levels With the Risk of Fractures in Patients With Severe Osteoporosis: The Japanese Osteoporosis Intervention Trial-05 (JOINT-05)

Shiro Tanaka, Mitsuru Saito, Hiroshi Hagino, Satoshi Mori, Toshitaka Nakamura, Hiroaki Ohta, Teruki Sone, Kaito Takahashi, Yuji Mitomo, Toshitsugu Sugimoto, Satoshi Soen

Summary: This study investigated the association between urinary pentosidine level and the risk of fracture in patients with severe osteoporosis. The results showed that urinary pentosidine level was associated with the incidence of vertebral and nonvertebral fractures, with the strongest association observed for nonvertebral fractures.

JBMR PLUS (2022)

Article Oncology

A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20)

Daisuke Tomizawa, Shin-ichi Tsujimoto, Shiro Tanaka, Jun Matsubayashi, Takahiro Aoki, Shotaro Iwamoto, Daisuke Hasegawa, Kozo Nagai, Kentaro Nakashima, Koji Kawaguchi, Takao Deguchi, Nobutaka Kiyokawa, Kentaro Ohki, Hidefumi Hiramatsu, Norio Shiba, Kiminori Terui, Akiko Moriya Saito, Motohiro Kato, Takashi Taga, Tsugumichi Koshinaga, Souichi Adachi

Summary: This study aims to establish an appropriate treatment for children with de novo acute myeloid leukemia, based on recurrent leukemic cytogenetic abnormalities and flow-cytometric minimal residual disease. It also aims to validate the safety and efficacy of gemtuzumab ozogamicin combined with post-induction chemotherapy for non-low-risk patients.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

暂无数据